Sources and sharing

BCTX - BriaCell Therapeutics Corp. Current Assets

Context
Latest reported period: Q1 2022
Latest reported value
$46,226,578

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Tracking and update notes

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 30 Apr 2022
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q1 2022.
  • Latest reported value on this page: $46,226,578.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Current Assets

New fact period available

Latest reported current assets: $46,226,578. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

30 Apr 2022

Page type

Metric history

Latest period

Q1 2022

SEC-backed company facts were refreshed from filings filed on 28 Oct 2026.

Benchmark Context

How Current Assets compares with peers

BriaCell Therapeutics Corp. sits in the upper half of the current current assets sample.

Compared with

Compared with 59 companies reporting current assets in USD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 1.3x the current sample midpoint. Current Assets does not yet have enough prior-period data for a historical comparison on this page.

  • Visible rows currently span reported period ends from 31 Dec 2017 to 30 Sep 2025.
  • Nearby companies in this sample: VCI Global Ltd and Profound Medical Corp..
  • Current sample position: rank #27 of 59 comparable companies.
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Financial Metric Page

BriaCell Therapeutics Corp.: Current Assets

Latest period: Q1 2022. Period end: 30 Apr 2022. Units: USD and CAD. Frequency: quarterly.

Current Assets is reported in company XBRL facts filed with the SEC.

What this metric tells you

  • Shows reported current assets over 01 Aug 2019 - 30 Apr 2022.
  • Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
  • Built from 7 SEC fact rows for this metric and issuer.

How to read this chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Current Assets levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

BriaCell Therapeutics Corp. appears at rank #27 in the latest comparison sample.

Rank Company Latest value Report period Next step
1 CRH PUBLIC LTD CO (crh) $14,801,000,000 Instant - 31 Dec 2022 Open CRH PUBLIC LTD CO Current Assets
2 CELESTICA INC (cls) $4,512,600,000 Instant - 31 Dec 2023 Open CELESTICA INC Current Assets
3 Atlassian Corp (team) $1,899,254,000 Instant - 30 Jun 2022 Open Atlassian Corp Current Assets
4 SSR MINING INC. (ssrm) $1,424,522,000 Instant - 31 Dec 2020 Open SSR MINING INC. Current Assets
5 Indivior Pharmaceuticals, Inc. (indv) $1,263,000,000 Instant - 31 Dec 2023 Open Indivior Pharmaceuticals, Inc. Current Assets
6 Flutter Entertainment plc (flut) $977,639,000 Instant - 31 Dec 2019 Open Flutter Entertainment plc Current Assets

Metric Details

Metric identity Names, identifiers, and filing context for this profile. 1 identity field
Taxonomy
ifrs-full
Metric coverage 3 source fields
Units tracked
USD and CAD
History range
01 Aug 2019 - 30 Apr 2022
Freshness: From parsed SEC XBRL facts on this page
Facts on this page
7
Source: SEC company facts API
Source evidence Original filing metadata and source links for verification. 1 source field
SEC metric endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Current Assets, Quarterly (USD)
Current Assets, YoY Quarterly Change (%)
Current Assets, Quarterly (CAD)
Current Assets, YoY Quarterly Change (%)

BriaCell Therapeutics Corp. Quarterly Current Assets (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2022 $46,226,578 30 Apr 2022 6-K 13 Jun 2022 2022 Q3
Q4 2021 $48,315,720 31 Jan 2022 6-K 15 Mar 2022 2022 Q2
Q2 2021 $57,798,150 +$57,536,687 +22006% 31 Jul 2021 6-K 13 Jun 2022 2022 Q3
Q2 2020 $261,463 +$92,930 +55% 31 Jul 2020 40-F/A 16 Nov 2021 2021 FY
Q2 2019 $168,533 01 Aug 2019 40-F/A 16 Nov 2021 2021 FY

BriaCell Therapeutics Corp. Quarterly Current Assets (CAD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2020 CA$321,208 +CA$114,166 +55% 31 Jul 2020 40-F/A 16 Nov 2021 2021 FY
Q2 2019 CA$207,042 01 Aug 2019 40-F/A 16 Nov 2021 2021 FY
* marks a reported value that did not pass the local value check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .